RSCM
CBST

Rail-Splitter Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Rail-Splitter Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-76,000
Closed -$5.56M – 53
2014
Q1 		$5.56M Sell
76,000
-2,900
-4% -$216K 1.84% 31
2013
Q4 		$5.43M Buy
+78,900
New +$5.11M 1.88% 34

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Rail-Splitter Capital Management's CBST Position: Q2 2014 in Review

Rail-Splitter Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 76,000 shares — an estimated $5.56M sold.

Rail-Splitter Capital Management first reported a position in CBST in Q4 2013 and held it in 2 quarters. The position peaked at $5.56M in Q1 2014. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Rail-Splitter Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Rail-Splitter Capital Management sold 76,000 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $5.56M.
  • Rail-Splitter Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Rail-Splitter Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $5.56M in Q1 2014.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Rail-Splitter Capital Management's 13F filing for Q2 2014, filed 10 Jul 2014.